YY1 and prostate cancer: We demonstrate that, when tested in vitro, using nuclear extracts from breast and prostate cancer cell lines, the YY1 protein was able to bind the non-risk allele (G) of 378854, a perfect proxy for the initially reported prostate cancer signal rs620861 [3], [6], more strongly than the risk allele.